Abstract

Objective: Drug resistance is considered one of the main threats for tuberculosis control. Our aim was to identify risk factors for drug resistance in tuberculosis patients in the Northern Portugal. Study Design and Methods: Retrospective case-control study. The medical records and drug susceptibility test data from TB patients diagnosed between 31 March 2009 and 1 April 2010 were examined. We enrolled 119 patients with any drug resistance to first line anti-TB drugs and 238 with drug-susceptible TB, matched by age group. Variables analyzed included: gender, country of origin, employment situation, site of disease, previous treatment, presence of diabetes mellitus, HIV infection, alcohol abuse, intravenous drug use, abuse of other drugs and smoking habits. Multivariate conditional logistic regression was used to identify independent predictors for drug-resistant TB. Results: Diabetes mellitus [adjusted odds ratio (OR): 3.54; 95% CI: 1.45 - 8.66], intravenous drug use (OR: 4.77; 95% CI: 1.24 - 18.32) and previous TB treatment (OR: 2.48; 95% CI: 1.12 - 5.49) were found to be risk factors for drug-resistant disease development. Conclusions: Diabetes mellitus, prior tuberculosis treatment, and intravenous drug use were risk factors for drug-resistant disease. The association between diabetes and drug-resistant TB should be further explored. Identifying clinical predictors of drug resistance can allow prompt identification of patients at risk for drug-resistant TB.

Highlights

  • Drug-resistant tuberculosis (TB) is a worldwide threat and constitutes an unparalleled challenge for disease control

  • Setting In Portugal, all patients with tuberculosis are treated under a National TB Control Program (NTP); patients are treated in specialized centers (Tuberculosis Units), medication is available through the NTP, is free of charge and is directly observed

  • The measure of association between drug resistance and each potential risk factor was reported by odds ratio (OR) and the 95% confidence intervals

Read more

Summary

Introduction

Drug-resistant tuberculosis (TB) is a worldwide threat and constitutes an unparalleled challenge for disease control. In 2008, the World Health Organization (WHO) estimated that more than 440,000 individuals had multidrugresistant tuberculosis (MDR-TB) worldwide Such patients are resistant to at least isoniazid and rifampicin, the most effective anti-TB drugs. In Europe, in 2009, the European Centre for Disease Prevention and Control estimated a proportion of 14.6% cases resistant to one or more first line anti-TB drugs (rifampicin, isoniazid, ethambutol, and streptomycin) and MDR-TB patients constituted 5.3% of all registered cases of TB [3]. In some areas (Lisbon and Porto) MDR-TB is endemic Another matter of concern is that the proportion of MDR-TB patients that are extensively drug-resistant (XDR-TB) ( having the poorest outcomes because virtually untreatable) is higher in Portugal (32%) than in Europe (7%) [4]-[6].

Setting
Design and Patients
Statistical Analysis
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call